Clinical Trial Update: Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating add-on levetiracetam for efficacy and tolerability in pediatric patients with refractory partial onset seizures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Phase 3 | Status: COMPLETED